Back to Research Hub
STAAR Surgical Company
STAA
$22.11-0.28 (-1.25%)
STAAR Surgical Company, along with its subsidiaries, specializes in ophthalmological solutions, focusing on the design, development, manufacturing, and commercialization of implantable lenses for vision correction, complete with the sophisticated delivery systems necessary for their implantation.
StreetsValue research for STAAR Surgical Company (STAA)
Members get the full report for STAAR Surgical Company: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.